Endocrine disrupters: from research to public health practice

被引:0
|
作者
Mantovani, Alberto [1 ]
Baldi, Francesca [1 ]
机构
[1] Ist Super Sanita, Dipartimento Sanit Pubbl Vet & Sicurezza Aliment, Reparto Tossicol Alimentare & Vet, I-00161 Rome, Italy
来源
EUROPEAN JOURNAL OF ONCOLOGY | 2012年 / 17卷 / 04期
关键词
metabolic syndrome; fertility; food safety; childhood; development; PERSISTENT ORGANIC POLLUTANTS; BISPHENOL-A; IN-VITRO; DEVELOPMENTAL EXPOSURE; TESTING STRATEGIES; ARSENIC EXPOSURE; SEMEN QUALITY; CHEMICALS; OBESITY; VIVO;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
An Endocrine Disrupter (ED) is an exogenous substance or a mixture, that alters function(s) of the endocrine system, causing adverse health effects in an intact organism, or its progeny, or particularly vulnerable (sub) populations. Reproductive health, prenatal and infant development are the most susceptible stages. EDs specific effects are closely associated with the respective mode of action, which can be very different e. g., nuclear receptor agonism or antagonism. EDs can be divided into four main groups: persistent pollutants that can bioaccumulate in animals and plants; pesticides, biocides and compounds used in animal husbandry; industrial chemicals widely used in consumer products such as bisphenol A and phthalates, less potent than persistent pollutants and pesticides, but with a more widespread exposure and still not adequately regulated; substances naturally occurring in diet such as the mycotoxin zearalenone or bioactive food components such as phytoestrogens. For many multifactorial endocrine-related diseases EDs should be considered as preventable risk factors; main examples are fertility disorders as well as predisposition to metabolic syndrome and some types of cancer. Independent research is essential to integrate and update risk assessment based on the mode of action understanding, the development of possible biomarkers for population studies as well as priorities and targets for risk management and communication. Eur. J. Oncol., 17 (4), 161-173, 2012
引用
收藏
页码:161 / 173
页数:13
相关论文
共 50 条
  • [1] Endocrine disrupters: from research to risk assessment
    Mantovani, Alberto
    La Rocca, Cinzia
    Maranghi, Francesca
    [J]. EPIDEMIOLOGIA & PREVENZIONE, 2009, 33 (1-2): : 5 - 7
  • [2] Endocrine disrupters: environment, health, public policies and the precautionary principle
    Vandelac, L
    [J]. BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2000, 184 (07): : 1477 - 1490
  • [3] Endocrine disrupters and male reproductive health
    Toppari, Jorma
    Virtanen, Helena E.
    Main, Katharina M.
    Skakkebaek, Niels E.
    [J]. ENDOCRINE JOURNAL, 2010, 57 : S287 - S287
  • [4] Endocrine disrupters and human health - Current research will establish baseline indices
    Harrison, PTC
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2001, 323 (7325): : 1317 - 1318
  • [5] Endocrine disrupters and female reproductive health
    McLachlan, JA
    Simpson, E
    Martin, M
    [J]. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 20 (01) : 63 - 75
  • [6] Endocrine disrupters - Cefic to select research facilities
    Scott, A
    [J]. CHEMICAL WEEK, 1997, 159 (09) : 15 - 15
  • [7] Removal of endocrine disrupters from the contaminated environment: public health concerns, treatment strategies and future perspectives - A review
    Werkneh, Adhena Ayaliew
    Gebru, Shifare Berhe
    Redae, Gebru Hailu
    Tsige, Arega Gashaw
    [J]. HELIYON, 2022, 8 (04)
  • [8] Endocrine disrupters
    Anon
    [J]. Chemical and Engineering News, 2001, 79 (31):
  • [9] Phytoestrogens, endocrine disrupters from food
    Bennetau-Pelissero, C
    Latonnelle, K
    Séqueira, A
    Lamothe, V
    [J]. ANALUSIS, 2000, 28 (09) : 763 - 775